Low grade fibromyxoid sarcoma of the falciform ligament: a case report
© Harish et al; licensee BioMed Central Ltd. 2003
Received: 05 June 2003
Accepted: 24 September 2003
Published: 24 September 2003
Low grade fibromyxoid sarcomas (LGFMS) are very rarely seen. They commonly arise from deep soft tissues of the lower extremities. Very few cases of intra-abdominal location have been reported.
We report a 37 year old man who presented with an abdominal mass and dragging pain. Pre-operative imaging suggested the possibility of a subcapsular hemangioma of liver.
Laparoscopy was useful to locate the tumor as arising from falciform ligament and made the subsequent surgery simpler. This is one of the large fibromyxoid sarcomas to be reported.
Low grade fibromyxoid sarcomas (LGFMS) of the soft tissues are usually situated in the deep soft tissues of the lower extremity, particularly the thigh . It is seen in a young or middle aged adult and is more common in the male. Though they are sporadically seen in other areas like the chest wall or shoulder they are very rarely reported in an intra-abdominal location. We report a 37-year old man with a giant intra-abdominal low grade fibromyxoid sarcoma measuring 21 cm in size; which was mistaken for a possible hemangioma of the liver on CT scan.
LGFMS was identified as a distinct entity in 1987 . Though patients as young as 3 years and as old as 78 years have been diagnosed with this tumor, it commonly afflicts young to middle aged adults, males more than females [1, 3–5].
Dragging of Glisson's capsule due to the large size probably accounts for pain in the present case as these are usually painless slowly growing masses. This mass was mistaken for a hemangioma for reasons cited earlier. Hence a pre-operative cytological diagnosis was not possible. In addition, needle aspiration study is not specific for diagnosis . This problem of diagnosis was partly circumvented by laparoscopy. The surgical plan was based on the laparoscopic findings and it helped in anatomic localization of the lesion. Further, the identification of large tortuous vessels in the vicinity of the tumor helped in reducing the hemorrhage at surgery. This vascular supply of the tumor accounts for the peripheral enhancement which led us to suspect a possible subcapsular hemangioma of the liver.
LGFMS usually arises in the deep soft tissue of the lower extremity particularly the thigh [1, 7]. Many of them arise in the skeletal muscle while some of them are confined to subcutaneous tissue . Although this patient did not show invasion of surrounding tissues on microscopy, these tumors could have extensive infiltration to surrounding tissues even when the tumor is grossly well circumscribed. These tumors have been described in locations like the chest wall, axilla, shoulder, inguinal region, buttock and the neck apart from thigh [1, 8–10]. Rare reports include those in the retroperitoneum, the small bowel mesentery, pelvis and the mediastinum [11–15]. Though a large LGFMS has been reported to arise from the abdominal wall , it has not been reported in the falciform ligament.
Immunohistochemically, the tumor cells stain strongly and diffusely for vimentin . Rarely, focal immunoreactivity could be seen for smooth muscle actin, desmin or cytokeratin [1, 17]. Though CD 34 is negative, one case of diffuse staining has been reported . LGFMS with giant rosettes has been identified as a separate entity but there are arguments to consider them as same tumor with some varying features on microscopy [3, 19]. In two LGFMS, no abnormal DNA content or chromosomal aberrations were noted but cytogenetic analysis revealed a ring chromosome in another report [20, 21]. In the present case, the cells expressed vimentin but there was no immunoreactivity with other markers.
LGFMS must be distinguished from myxofibrosarcoma as their clinical behaviors are different with LGFMS likely to metastasize more often . The latter lacks areas of fibrous stroma, is uniformly myxoid and in addition it does not show whorled arrangement of tumor cells . Other malignant tumors that need to be distinguished from LGFMS include malignant peripheral nerve sheath tumor and spindle cell liposarcoma . More often these lesions are mistaken for benign lesions like myxoid neurofibroma, desmoid fibromatosis, perineuroma or nodular fascitis [1, 23]. The initial evaluation led us to believe that the tumor was a fibrous histiocytoma. However, with the study of more sections and the help of a reference pathologist, the tumor was diagnosed as LGFMS. The other lesions described above have been excluded in the present case by microscopic findings and immunohistochemistry.
These tumors have been reported to recur and metastasize [1, 10, 24]. These tumors have recurred as early as 6 months to as late as 50 years in 65% of patients. Metastasis also has been reported to occur frequently with lung being a common site. These tumors have a protracted course even after metastasis. Interestingly, in a larger study, only 5% metastasis has been reported attributing this to prospectively following up a low grade sarcoma while earlier studies have worked back on a metastatic disease . Although a satisfactory wide excision with an intact capsule was possible, as the tumor was large and deep seated, this patient is kept under follow-up. Patient is recurrence free at one year. Adjuvant radiation was not considered in view of the peculiar position of the tumor. Responses to chemotherapy have been poor and with the limited experience must be considered investigational.
Even with advent of many imaging modalities, in certain situations like the one described, a cytopathological diagnosis may not be technically feasible. Diagnostic laparoscopy would be very useful for anatomic localization. Proper histopathologic evaluation of the tumor and immunohistochemistry is necessary for accurate diagnosis. Exclusion of other similar appearing tumors is essential.
List of abbreviations used
- LGFMS :
Low grade fibromyxoid sarcoma
Dr. Rekha V Kumar, Associate Professor of Pathology at the Kidwai Memorial Institute of Oncology (A Regional Cancer Center), Bangalore, INDIA was the reference pathologist. We wish to thank her for helping us with the pathologic study of the tumor including the immunohistochemical study.
"Written consent was obtained from the patient for publication of the patient's details."
- Weiss SW, Goldblum JR: Benign fibrohistiocytic tumors. In Soft tissue tumors. Edited by: Enzinger FM, Weiss SW Mosby. 2001, 409-39. 4Google Scholar
- Evans HL: Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol. 1987, 88 (5): 615-9.View ArticlePubMedGoogle Scholar
- Folpe AL, Lane KL, Paull G, Weiss SW: Low-grade fibromyxoid sarcoma and hyalinizing spindle cell tumor with giant rosettes: a clinicopathologic study of 73 cases supporting their identity and assessing the impact of high-grade areas. Am J Surg Pathol. 2000, 24 (10): 1353-60.View ArticlePubMedGoogle Scholar
- Kataoka Y, Matsuda M, Katsura T, Tanaka K, Ebara H, Yoshida F, Takaba E, Takimoto M: Case of low-grade fibromyxoid sarcoma [in Japanese]. Nippon Naika Gakkai Zasshi. 1997, 86 (8): 1458-60.View ArticlePubMedGoogle Scholar
- Canpolat C, Evans HL, Corpron C, Andrassy RJ, Chan K, Eifel P, Elidemir O, Raney B: Fibromyxoid sarcoma in a four-year-old child: case report and review of the literature. Med Pediatr Oncol. 1996, 27 (6): 561-4. 10.1002/(SICI)1096-911X(199612)27:6<561::AID-MPO10>3.3.CO;2-F.View ArticlePubMedGoogle Scholar
- Lindberg GM, Maitra A, Gokaslan ST, Saboorian MH, Albores-Saavedra J: Low grade fibromyxoid sarcoma: fine-needle aspiration cytology with histologic, cytogenetic, immunohistochemical, and ultrastructural correlation. Cancer. 1999, 87 (2): 75-82. 10.1002/(SICI)1097-0142(19990425)87:2<75::AID-CNCR6>3.3.CO;2-N.View ArticlePubMedGoogle Scholar
- Ugai K, Kizaki T, Morimoto K, Sashikata T: A case of low-grade fibromyxoid sarcoma of the thigh. Pathol Int. 1994, 44 (10–11): 793-9.PubMedGoogle Scholar
- Husek K, Janicek P, Jelinek O: Low grade malignant fibromyxoid sarcoma [In Czech with English abstract]. Cesk Patol. 1998, 34 (4): 139-4.PubMedGoogle Scholar
- Zamecnik M, Michal M: Low-Grade Fibromyxoid Sarcoma: A Report of Eight Cases With Histologic, Immunohistochemical, and Ultrastructural Study. Ann Diagn Pathol. 2000, 4: 207-17. 10.1053/adpa.2000.8122.View ArticlePubMedGoogle Scholar
- Devaney DM, Dervan P, O'Neill S, Carney D, Leader M: Low-grade fibromyxoid sarcoma. Histopathology. 1990, 17 (5): 463-5.View ArticlePubMedGoogle Scholar
- Evans HL: Low-grade fibromyxoid sarcoma. A report of 12 cases. Am J Surg Pathol. 1993, 17 (6): 595-600.View ArticlePubMedGoogle Scholar
- Goodlad JR, Mentzel T, Fletcher CD: Low grade fibromyxoid sarcoma: clinicopathological analysis of eleven new cases in support of a distinct entity. Histopathology. 1995, 26 (3): 229-37.View ArticlePubMedGoogle Scholar
- Kaji M, Konishi K, Funaki K, Nukui A, Goka T, Arakawa G, Onishi I, Kimura H, Maeda K, Yabushita K, Tsuji M, Yamashita H, Miwa A: A case of low-grade fibromyxoid sarcoma of the small bowel mesentery [In Japanese]. Nippon Shokakibyo Gakkai Zasshi. 1999, 96 (6): 670-4.PubMedGoogle Scholar
- Shidham VB, Ayala GE, Lahaniatis JE, Garcia FU: Low-Grade Fibromyxoid Sarcoma: Clinicopathologic Case Report With Review of the Literature. Am J Clin Oncol. 1999, 22 (2): 150-5. 10.1097/00000421-199904000-00009.View ArticlePubMedGoogle Scholar
- Takanami I, Takeuchi K, Naruke M: Low-grade fibromyxoid sarcoma arising in the mediastinum. J Thorac Cardiovasc Surg. 1999, 118 (5): 970-1.View ArticlePubMedGoogle Scholar
- van den Bossche MR, Van Mieghem H: Low-grade fibromyxoid sarcoma. Oncology. 2000, 58 (3): 207-9. 10.1159/000012101.View ArticlePubMedGoogle Scholar
- Fukunaga M, Ushigome S, Fukunaga N: Low-grade fibromyxoid sarcoma. Virchows Archiv. 1996, 429 (4–5): 301-3.PubMedGoogle Scholar
- Nichols GE, Cooper PH: Low-grade fibromyxoid sarcoma: case report and immunohistochemical study. J Cutan Pathol. 1994, 21 (4): 356-62.View ArticlePubMedGoogle Scholar
- Lane KL, Shannon RJ, Weiss SW: Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am J Surg Pathol. 1997, 21 (12): 1481-8. 10.1097/00000478-199712000-00011.View ArticlePubMedGoogle Scholar
- Mezzelani A, Sozzi G, Nessling M, Riva C, Della Torre G, Testi MA, Azzarelli A, Pierotti MA, Lichter P, Pilotti S: Low grade fibromyxoid sarcoma. a further low-grade soft tissue malignancy characterized by a ring chromosome. Cancer Genet Cytogenet. 2000, 122 (2): 144-8. 10.1016/S0165-4608(00)00288-0.View ArticlePubMedGoogle Scholar
- Akoi T, Hisaoka M, Kouho H, Hashimoto H, Nakata H: Interphase cytogenetic analysis of myxoid soft tissue tumors by fluorescence in situ hybridization and DNA flow cytometry using paraffin embedded tissue. Cancer. 1997, 79: 284-93. 10.1002/(SICI)1097-0142(19970115)79:2<284::AID-CNCR12>3.0.CO;2-X.View ArticleGoogle Scholar
- Mentzel T, Katenkamp D, Fletcher CD: Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course [in German with English abstract]. Pathologe. 1996, 17 (2): 116-21. 10.1007/s002920050142.View ArticlePubMedGoogle Scholar
- Hollowood K, Fletcher CD: Soft tissue sarcomas that mimic benign lesions. Semin Diagn Pathol. 1995, 12 (1): 87-97.PubMedGoogle Scholar
- Dvornik G, Barbareschi M, Gallotta P, Palma PD: Low grade fibromyxoid sarcoma. Histopathology. 1997, 30 (3): 274-6. 10.1046/j.1365-2559.1997.d01-595.x.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2482/3/7/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.